| Nonbiopsy diagnosis of cardiac transthyretin amyloidosis JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ... Circulation 133 (24), 2404-2412, 2016 | 1924 | 2016 |
| Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 GB Johnson, GJ Brunn, Y Kodaira, JL Platt The Journal of Immunology 168 (10), 5233-5239, 2002 | 801 | 2002 |
| Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis A Castano, M Haq, DL Narotsky, J Goldsmith, RL Weinberg, ... JAMA cardiology 1 (8), 880-889, 2016 | 413 | 2016 |
| Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 GB Johnson, GJ Brunn, JL Platt The Journal of Immunology 172 (1), 20-24, 2004 | 310 | 2004 |
| PET/MRI: where might it replace PET/CT? EC Ehman, GB Johnson, JE Villanueva‐Meyer, S Cha, AP Leynes, ... Journal of Magnetic Resonance Imaging 46 (5), 1247-1262, 2017 | 301 | 2017 |
| Activation of mammalian Toll-like receptors by endogenous agonists GB Johnson, GJ Brunn, JL Platt Critical Reviews™ in Immunology 23 (1-2), 2003 | 205 | 2003 |
| Conditional signaling by Toll‐like receptor 4 GJ Brunn, MK Bungum, GB Johnson, JL Platt The FASEB journal 19 (7), 1-16, 2005 | 147 | 2005 |
| Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission BP McMenomy, AN Kurup, GB Johnson, RE Carter, RR McWilliams, ... Journal of Vascular and Interventional Radiology 24 (2), 207-213, 2013 | 145 | 2013 |
| Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction OF AbouEzzeddine, DR Davies, CG Scott, AU Fayyaz, JW Askew, ... JAMA cardiology 6 (11), 1267-1274, 2021 | 142 | 2021 |
| Evolutionary clues to the functions of the Toll-like family as surveillance receptors GB Johnson, GJ Brunn, AH Tang, JL Platt Trends in immunology 24 (1), 19-24, 2003 | 135 | 2003 |
| Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors JL Kujak, PT Liu, GB Johnson, MR Callstrom Skeletal radiology 39, 175-182, 2010 | 124 | 2010 |
| Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis M Mahmood, AT Kendi, S Farid, S Ajmal, GB Johnson, LM Baddour, ... Journal of Nuclear Cardiology 26 (3), 958-970, 2019 | 119 | 2019 |
| Structural and functional imaging in parkinsonian syndromes SM Broski, CH Hunt, GB Johnson, RF Morreale, VJ Lowe, PJ Peller Radiographics 34 (5), 1273-1292, 2014 | 101 | 2014 |
| Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma GR Johnson, H Zhuang, J Khan, SB Chiang, A Alavi Clinical nuclear medicine 28 (10), 815-820, 2003 | 96 | 2003 |
| Evaluation of 18F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors SM Broski, GB Johnson, BM Howe, MA Nathan, DE Wenger, RJ Spinner, ... Skeletal Radiology 45, 1097-1105, 2016 | 87 | 2016 |
| A genetic basis for the “Adonis” phenotype of low adiposity and strong bones GB Johnson, BL Riggs, JL Platt The FASEB Journal 18 (11), 1282-1284, 2004 | 79 | 2004 |
| clinical PET/MRI: 2018 update SM Broski, AH Goenka, BJ Kemp, GB Johnson American Journal of Roentgenology 211 (2), 295-313, 2018 | 76 | 2018 |
| The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma SM Broski, CH Hunt, GB Johnson, RM Subramaniam, PJ Peller Journal of Nuclear Medicine 53 (8), 1200-1206, 2012 | 70 | 2012 |
| 18F-FDG PET/CT in Erdheim–Chester disease: imaging findings and potential BRAF mutation biomarker JR Young, GB Johnson, RC Murphy, RS Go, SM Broski Journal of Nuclear Medicine 59 (5), 774-779, 2018 | 66 | 2018 |
| New insight into the pathogenesis of sepsis and the sepsis syndrome GB Johnson, GJ Brunn, B Samstein, JL Platt Surgery 137 (4), 393-395, 2005 | 64 | 2005 |